Weixing Shen
Impact in
-
- Acupuncture Treatment Research Studies
- Traditional Chinese Medicine Analysis
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Phosphodiesterase function and regulation 5
- Ubiquitin and proteasome pathways 3
- Oncology 13
- Cancer Cells and Metastasis 3
- Co-authors
- Haibo Cheng (36 shared papers)Jiani Tan (23 shared papers)Changliang Xu (23 shared papers)Dongdong Sun (30 shared papers)Qibiao Wu (10 shared papers)Xiaoyan Shen (8 shared papers)Liu Li (10 shared papers)Matthew A. Movsesian (3 shared papers)
- Journals
- Phytomedicine (8 papers)Journal of Ethnopharmacology (6 papers)Frontiers in Oncology (3 papers)Chemico-Biological Interactions (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Weixing Shen
81 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 124
- Complementary and alternative medicine 210
- Pharmacology 120
- Cancer Research 171
- Neurology 90
- Molecular Biology 753
Countries citing papers authored by Weixing Shen
This map shows the geographic impact of Weixing Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixing Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixing Shen more than expected).
Fields of papers citing papers by Weixing Shen
This network shows the impact of papers produced by Weixing Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixing Shen. The network helps show where Weixing Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixing Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 108 | |
| 2 | 2012 | 82 | |
| 3 | 2015 | 71 | |
| 4 | 2014 | 64 | |
| 5 | 2021 | 61 | |
| 6 | 2020 | 53 | |
| 7 | 2015 | 52 | |
| 8 | 2014 | 50 | |
| 9 | 2014 | 50 | |
| 10 | 2019 | 50 | |
| 11 | 2014 | 50 | |
| 12 | 2015 | 44 | |
| 13 | 2016 | 44 | |
| 14 | 2011 | 44 | |
| 15 | 2018 | 43 | |
| 16 | 2014 | 41 | |
| 17 | 2021 | 35 | |
| 18 | 2015 | 34 | |
| 19 | 2016 | 33 | |
| 20 | 2011 | 33 |
About Weixing Shen
Weixing Shen is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 1.7k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (5 papers), Immune cells in cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Acupuncture Treatment Research Studies (3 papers), Cancer Cells and Metastasis (3 papers), Flavonoids in Medical Research (3 papers), Topic Modeling (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Complementary and alternative medicine (210 citations), Pharmacology (120 citations), Cancer Research (171 citations), Neurology (90 citations) and Molecular Biology (753 citations). Weixing Shen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Haibo Cheng, Jiani Tan, Changliang Xu, Dongdong Sun, Qibiao Wu, Xiaoyan Shen, Liu Li, Matthew A. Movsesian, Faiyaz Ahmad and Bing‐Mei Zhu. Their work appears in journals such as Phytomedicine, Journal of Ethnopharmacology, Frontiers in Oncology, Chemico-Biological Interactions and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.